Related Experiment Videos
A positive pharmacological erection test does not rule out arteriogenic erectile dysfunction
L Cormio1, H Nisén, F P Selvaggi
1Department of Urology R, School of Medicine, University of Bari, Italy.
The Journal of Urology
|November 1, 1996
Summary
A positive pharmacological erection test does not guarantee normal penile vascular status in men with erectile dysfunction. Some patients with arterial insufficiency may still achieve a rigid erection after prostaglandin E1 injection.
Area of Science:
- Urology
- Andrology
- Vascular Medicine
Background:
- Erectile dysfunction (ED) is a common condition affecting many men.
- Penile vascular status is crucial for achieving and maintaining an erection.
- The pharmacological erection test (PET) is used to assess erectile function.
Purpose of the Study:
- To evaluate the assumption that a positive PET indicates normal penile vascular status.
- To determine if a rigid erection post-injection rules out underlying vascular issues.
Main Methods:
- Color-coded Doppler ultrasonography was used to study penile hemodynamics.
- 205 patients with ED underwent the test after intracavernous prostaglandin E1 injection.
- Analysis included peak systolic velocity and resistance index.
Main Results:
- 82% of patients with a positive PET had normal arterial function.
- 10% of patients with a positive PET showed signs of arterial insufficiency.
- Patients with arterial insufficiency often had risk factors like diabetes and hypertension.
Conclusions:
- A positive PET does not exclude arteriogenic erectile dysfunction.
- Hemodynamic assessment is necessary for a comprehensive evaluation of ED.
- Further investigation is needed for patients with risk factors despite a positive PET.